Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

BackgroundThe mechanisms underlying altered susceptibility and propensity to severe Coronavirus disease 2019 (COVID-19) disease in at-risk groups such as patients with chronic obstructive pulmonary disease (COPD) are poorly understood. Inhaled corticosteroids (ICSs) are widely used in COPD, but the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lydia J. Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V. Kemp, Maria-Belen Trujillo-Torralbo, Su-Ling Loo, Maria Adelaide Calderazzo, Jadwiga A. Wedzicha, Patrick Mallia, Nathan W. Bartlett, Sebastian L. Johnston, Aran Singanayagam
Médium: Artigo
Jazyk:angličtina
Vydáno: 2020
On-line přístup:https://doi.org/10.1016/j.jaci.2020.09.034
http://www.jacionline.org/article/S009167492031407X/pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1016/j.jaci.2020.09.034
http://www.jacionline.org/article/S009167492031407X/pdf

Podobné jednotky